Lna Santé S.A (LNA) | Stock Overview & Key Data
Lna Santé S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €68.60 on June 12, 2017
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lna Santé S.A
LNA
|
297.53M Mid-cap | -2.94% | 9.27% | 18.71% | 18.71% | 18.71% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% |
|
Emeis S.A
EMEIS
|
2.28B Large-cap | -2.97% | -9.31% | -2.28% | 4.65% | -6.09% | 35.08% | -91.30% | -99.79% | -99.68% | -99.55% | -99.55% |
|
Orpea
ORP
|
2.19B Large-cap | -3.09% | -8.72% | 7.30% | 7.30% | 7.30% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% |
|
Clariene SE
CLARI
|
1.36B Large-cap | -0.74% | -5.16% | 15.10% | 15.10% | 15.10% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% |
| 1.10B Large-cap | -0.44% | 8.74% | 7.18% | 24.44% | 19.91% | 1.34% | -43.25% | -42.39% | -9.42% | 37.08% | 37.08% | |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
Ownership & Short Interest
Calculate Your Lna Santé S.A Investment Returns
Long-Term Investment Performance Analysis
Lna Santé S.A stock price in Mar 2026 was €26.40, A €1,000.00 lump sum investment in Lna Santé S.A made 0 years ago would be worth approximately €1,250.00 today, representing a positive return of 25.00%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LNA's 52-week high and low?
- In the last 52 weeks, Lna Santé S.A reached a high of €34.30 (on June 10, 2026) and a low of €22.60 (on N/A).
- What is the market cap and P/E ratio for LNA?
- Curious about Lna Santé S.A's size and valuation? Its market capitalization stands at 297.53M. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.34, and the forward P/E (looking ahead) is 9.36.
- Does LNA pay dividends? If so, what's the yield?
- Yes, Lna Santé S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.50%, and the company has paid an average of €0.58 per share annually over the past 3 years.
- Who are Lna Santé S.A's main competitors or similar companies to consider before investing?
When looking at Lna Santé S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.28B Healthcare Medical Care Facilities 35.08% -91.30% Orpea
ORP2.19B Healthcare Medical Care Facilities 12.35% 12.35% Clariene SE
CLARI1.36B Healthcare Medical Care Facilities 20.23% 20.23% Ramsay Générale de
GDS1.10B Healthcare Medical Care Facilities 1.34% -43.25% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lna Santé S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Lna Santé S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.74%, the Debt to Equity ratio from the most recent quarter is 2.75, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for LNA?
- Looking at Lna Santé S.A's growth, its revenue over the trailing twelve months (TTM) was €913M. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.80%, and quarterly earnings saw a YoY growth of 35.80%.
- How much of LNA stock is held by insiders and institutions?
- Wondering who owns Lna Santé S.A stock? Company insiders (like executives and directors) hold about 54.53% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.